18F-fluciclovine positron emission tomography (PET) in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.

Pedro C. Barata,Charlotte Manogue,Ellen Jaeger,Malcolm Light,Patrick Cotogno,Elisa Ledet,Janeiro Valle Goffin,Jodi Lyn Layton,Brian E. Lewis,A. Oliver Sartor

18F-fluciclovine positron emission tomography (PET) in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.

2021

Pedro C. Barata
Charlotte Manogue
Ellen Jaeger
Malcolm Light
Patrick Cotogno
Elisa Ledet
Janeiro Valle Goffin
Jodi Lyn Layton
Brian E. Lewis
A. Oliver Sartor

TPS171Background: Conventional imaging of prostate cancer has limitations in staging, restaging after biochemical relapse, and response assessment. Functional imaging with positron emission tomogra...

Keywords:

Abiraterone acetate
Prostate cancer
Positron emission tomography
castration resistant
response assessment
Positron emission
Radiology
Medicine
Stage (cooking)
Functional imaging

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations